Acetaminophen Market Analysis

  • Report ID: 6190
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Acetaminophen Market Analysis

Dosage Form (Tablets, Liquid Suspension)

Tablets segment is estimated to dominate over 57% acetaminophen market share by 2037. More than 90 million high-temperate cases occur per week, requiring the administering of acetaminophen. Acetaminophen tablets are also preferred in patients with peptic ulcers, and those who cannot tolerate aspirin. Despite having high absorption properties, one would have to consume high-dose acetaminophen for an extended period of time before the first side effect appears. Since the system efficiently absorbs it in a span of 60 minutes, tablet routes are preferred over liquid suspension, or IV due to its affordability and convenience. Also, administering acetaminophen through the oral route is noted to have the least amount of side effects.

Route of Administration (Oral, Parenteral)

By 2037, oral segment is poised to dominate over 33% acetaminophen market share. Acetaminophen is administered to both in-patient and outpatient patients, with dosage depending upon the age and weight of the individual.  The parenteral dosage is preferred among patients suffering from severe nausea. Fevers are the most common occurrence and in its treatment, acetaminophen is administered in combination with other viral medications. The pandemic caused by COVID-19 also shot up the demand for oral acetaminophen in the global market, even leading to instances of shortage. Also, used in pain relief, 1 in 10 people suffer from chronic pain, requiring the administering of acetaminophen combination drugs 

Application (Common Cold, Pain Relief)

In acetaminophen market, common-cold segment is anticipated to dominate over 30% revenue share by 2037. On average, a person gets symptoms of the common cold, 4-6 times a year. There are no treatments for viral infections like the common cold. The only approach is to tend to the symptoms like headache, stuffed nose, and body aches, for which acetaminophen is prescribed, through various routes of administration. An average adult is said to experience cold symptoms at least 3 times a year. Acetaminophen finds its most application in these cases. It is also found in combination with other drugs in allergy medications, sleep medications, etc.

Our in-depth analysis of the global acetaminophen market includes the following segments:

         Dosage Form

  • Tablets
  • Liquid Suspension

         Route of Administration

  • Oral
  • Parenteral

         Application

  • Common Cold
  • Pain Relief
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6190
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of acetaminophen is estimated at USD 11.22 billion.

The acetaminophen market size was valued at USD 10.83 billion in 2024 and is likely to cross USD 19.19 billion by 2037, expanding at more than 4.5% CAGR during the forecast period i.e., between 2025-2037. The use of acetaminophen has been widely approved for decades to treat aches and fevers, even in children, as long as the maximum dosage is 15mg/kg for a single dose.

North America industry is likely to account for largest revenue share of 37% by 2037, due to robust health infrastructure, the presence of industry key players in the region.

The major players in the market are Sanofi, Dr. Reddy Laboratories, Pfizer, Bayer, Aurobindo, Sun Pharma, Lupin, Abbott, Novartis, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample